KLF5 and neoplasm: circCRKL was revealed to act as a tumor suppressor in PC by binding miR-141, leading to the upregulation of miR-141 target KLF5, repressed cell cycle, invasion, migration, boosted apoptosis of PC cells, and reduced tumor progression in vivo [98].